Accuracy of a Continuous Ketone Monitoring (CKM) System in Individuals With Type 1 Diabetes on Insulin Pump Therapy.

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

February 18, 2025

Study Completion Date

July 18, 2025

Conditions
type1diabetes
Interventions
OTHER

Ketogenic diets

During the outpatient phase of the study, all participants will undergo a very low-carbohydrate diet (less than 50grams/day) and, a fasting diet (12 hours) in a randomized order. Both diets are 6 days in duration and, will be interspaced by an inpatient insulin-suspension period. These ketogenic diets are implemented to drive higher ketone levels, within a safe threshold, to assess the accuracy of the CKM sensor. All the while, study participants will be wearing the CKM and, taking multiple daily ketone measurements with a standard point-of-cate ketone meter.

OTHER

8-hour insulin-suspension period

Interspaced between both ketogenic diets, on day 8 of the study, participants will have their insulin pumps suspended for 8 hours; therefore, participants will not receive any basal or bolus insulin. Ketone levels will be monitored on-site every 30 minutes with standard point-of-care capillary ketone meters and, if ketones measurements exceed the safety threshold, participants will be treated accordingly. Clearly defined stopping criteria and corrective treatments have been outlined in the study protocol to ensure participants safety.

Trial Locations (1)

H4A 3T2

Hygea Clinic, Montreal

All Listed Sponsors
lead

McGill University

OTHER

NCT06420518 - Accuracy of a Continuous Ketone Monitoring (CKM) System in Individuals With Type 1 Diabetes on Insulin Pump Therapy. | Biotech Hunter | Biotech Hunter